Introduction
The management of localized penile cancer is based on organ-sparing approaches. Our
aim is to report surgical outcomes of glansectomy (GS) and split thickness skin graft
(STSG) reconstruction in a consecutive series of penile cancers.
Patients and Methods
Patients with a localized penile cancer underwent GS and STSG reconstruction in tertiary
referral center. Data were extrapolated from a single center prospective database
starting from May 2013 to August 2019. Two different techniques are presented in the
video abstract: - a standard GS with dissection over the Bucks’ fascia. - a salvage
GS with dissection under Bucks’ fascia.
Results
A total of 34 patients were enrolled. 30 patients underwent a standard GS, whether
a salvage GS was performed in the remainders. The apex of corpora cavernosa was transected
in 5 cases due to suspicious of local invasion. Median follow-up was 12 (12-41) months.
Operative time was 150 (105-180) minutes. Hospital stay was 2 (1-3) days. A modified
TODGA compressive dressing and a catheter were applied and left in place for 5 days.
After that a saline washing was used for 2 weeks. The incidence of intraoperative
complications was minimal (2.9%). Positive surgical margins were detected in 2.9%
of cases, requiring a salvage surgery. The incidence of postoperative complications
was 29.4%: 11.7% were classified as Grade 1, 8.8% as Grade 2 and 8.8% as Grade 3a
according to Clavien-Dindo classification. 1-year recurrence free-survival (RFS) was
88.2%. 1-y cancer-specific (CSS) and overall survival (OS) resulted 91.2% in both
cases. Limitations of the study were the retrospective and single centre nature of
the study, the lack of comparative group, the limited number of cases and of follow-up.
Conclusions
GS and STSG reconstruction represents a safe procedure burden by a low incidence of
postoperative complications providing a satisfactory cancer control, with a minimal
risk of local recurrence.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to UrologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article Info
Publication History
Published online: March 31, 2021
Accepted:
March 22,
2021
Received:
February 7,
2021
Identification
Copyright
© 2021 Elsevier Inc. All rights reserved.
